The WACC of Vireo Health International Inc (VREO.CN) is 12.2%.
Range | Selected | |
Cost of equity | 9.80% - 13.00% | 11.40% |
Tax rate | 25.90% - 26.50% | 26.20% |
Cost of debt | 16.70% - 20.20% | 18.45% |
WACC | 10.7% - 13.6% | 12.2% |
Category | Low | High |
Long-term bond rate | 3.2% | 3.7% |
Equity market risk premium | 5.1% | 6.1% |
Adjusted beta | 1.31 | 1.45 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 9.80% | 13.00% |
Tax rate | 25.90% | 26.50% |
Debt/Equity ratio | 0.54 | 0.54 |
Cost of debt | 16.70% | 20.20% |
After-tax WACC | 10.7% | 13.6% |
Selected WACC | 12.2% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for VREO.CN:
cost_of_equity (11.40%) = risk_free_rate (3.45%) + equity_risk_premium (5.60%) * adjusted_beta (1.31) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.